No Cover Image

Journal article 210 views 37 downloads

The Impact of Probiotic Supplementation on the Development of the Infant Gut Microbiota: An Exploratory Follow-Up of a Randomised Controlled Trial

Niall Coates Orcid Logo, Daniel A. John, Sue Jordan Orcid Logo, Mel Storey, Cathy Thornton Orcid Logo, Iveta Garaiova Orcid Logo, Duolao Wang Orcid Logo, Stephen J. Allen Orcid Logo, Daryn R. Michael Orcid Logo, Susan F. Plummer, Paul Facey Orcid Logo

Microorganisms, Volume: 13, Issue: 5, Start page: 984

Swansea University Authors: Sue Jordan Orcid Logo, Mel Storey, Cathy Thornton Orcid Logo, Paul Facey Orcid Logo

  • 69374.VoR.pdf

    PDF | Version of Record

    © 2025 by the authors. This is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.

    Download (8.9MB)

Abstract

Early-life establishment of the gut microbiota plays a role in lifelong health, with disruptions linked to heightened risks of metabolic and immune disorders. Probiotic supplementation may be used to modulate the infant gut microbiome to promote favourable development. Here, we evaluate how Lab4B pr...

Full description

Published in: Microorganisms
ISSN: 2076-2607
Published: MDPI AG 2025
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa69374
Abstract: Early-life establishment of the gut microbiota plays a role in lifelong health, with disruptions linked to heightened risks of metabolic and immune disorders. Probiotic supplementation may be used to modulate the infant gut microbiome to promote favourable development. Here, we evaluate how Lab4B probiotic supplementation shapes the development of the infant gut microbiome over the first 6 months. Faecal samples collected from infants enrolled in PROBAT (ISRCTN26287422), a randomised, double-blind, placebo-controlled trial, were analysed using culture-dependent and -independent (16S rDNA and metagenomic shotgun sequencing) techniques to examine the composition, diversity, and metabolic capabilities of the microbiome, as well as the abundance of antimicrobial resistance genes (ARGs). Probiotic supplementation encouraged the development of a microbiome with a distinct composition characterised by elevated abundances of Bifidobacteriaceae in the first 6 weeks (p = 0.006) and Lactobacillaceae throughout the first 6 months (p < 0.05 at every 6-week time point), accelerated microbial diversification, reduced abundance of beta-lactam- and cephalosporin-resistance genes, and differences in predicted metabolic capabilities at the start and end points. Supplementation of this neonatal population, which is at high risk of atopy, with the Lab4B probiotic significantly influenced the development of the infant gut microbiota during the first 6 months.
Keywords: infant gut microbiota development; multi-strain probiotic; atopy; DNA sequencing
College: Faculty of Medicine, Health and Life Sciences
Funders: This research was funded by the Knowledge Exploitation Fund, Collaborative Industrial Research (Project No. HE09 COL 1002), European Regional Development Fund (ERDF) Accelerate Programme (Project code: PR-0228) and Cultech Ltd. (Port Talbot, UK).
Issue: 5
Start Page: 984